{
    "clinical_study": {
        "@rank": "90763", 
        "acronym": "EVLP_MI", 
        "arm_group": [
            {
                "arm_group_label": "Standard Group", 
                "arm_group_type": "No Intervention", 
                "description": "Recipients of lungs procured from brain death donors deemed suitable for transplantation according to standard criteria.\nEvents: lung procurement, cold storage on ice, transplantation."
            }, 
            {
                "arm_group_label": "EVLP Group", 
                "arm_group_type": "Experimental", 
                "description": "Recipients of marginal lungs procured from brain death donors and reconditioned with ex-vivo lung perfusion (EVLP).\nEvents: lung procurement, cold storage on ice, reconditioning by EVLP,  cold storage on ice, transplantation."
            }
        ], 
        "brief_summary": {
            "textblock": "The recent introduction of ex-vivo lung perfusion (EVLP) as a tool to evaluate and\n      recondition lungs from marginal donors has opened a new era in the field of lung\n      transplantation."
        }, 
        "brief_title": "Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Disorder Related to Lung Transplantation", 
            "Brain Death", 
            "Graft Failure", 
            "Primary Graft Dysfunction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Brain Death", 
                "Primary Graft Dysfunction"
            ]
        }, 
        "detailed_description": {
            "textblock": "Aim of the investigation: to compare the clinical outcome after transplantation of subjects\n      receiving marginal lungs procured from brain death donors and reconditioned by EVLP, with\n      that of subjects receiving lungs procured from standard donors."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria for donor lung:\n\n          1. Recipient to undergo single or bilateral Lung Transplantation\n\n          2. Donor arterial partial pressure of oxygen to fraction of inspired oxygen ratio\n             (PaO2/FiO2) below 300 mmHg, or doubtful donor lung function\n\n        Exclusion criteria for donor lung:\n\n          1. Massive lung contusion\n\n          2. Aspiration\n\n          3. Pneumonia\n\n          4. Sepsis\n\n          5. Malignancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "7", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01967953", 
            "org_study_id": "EVLP_2011"
        }, 
        "intervention": {
            "arm_group_label": "EVLP Group", 
            "description": "EVLP technique: Steen solution; normothermia; low flow, open atrium, low hematocrit.\nEndpoints of EVLP assessment of lungs suitability: oxygenation, respiratory mechanics, pulmonary vascular resistance, chest X-ray, fibrobronchoscopy", 
            "intervention_name": "EVLP Group", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 22, 2013", 
        "link": {
            "description": "Lung transplantation", 
            "url": "http://nlm.nih.gov/medlineplus/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy", 
                    "zip": "20122"
                }, 
                "name": "Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ex-Vivo Lung Perfusion to Improve Donor Lung Function and Increase the Number of Organs Available for Transplantation", 
        "overall_official": {
            "affiliation": "Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico Milan Italy", 
            "last_name": "Franco Valenza, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Primary Graft Dysfunction 72 hours after transplantation (PGD72) definition: grade 3 according to the International Society of Heart and Lung Transplantation classification", 
                "measure": "Primary Graft Dysfunction 72 hours after lung transplantation (PGD72)", 
                "safety_issue": "Yes", 
                "time_frame": "72 hours"
            }, 
            {
                "measure": "30 day Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "reference": [
            {
                "PMID": "21488765", 
                "citation": "Cypel M, Yeung JC, Liu M, Anraku M, Chen F, Karolak W, Sato M, Laratta J, Azad S, Madonik M, Chow CW, Chaparro C, Hutcheon M, Singer LG, Slutsky AS, Yasufuku K, de Perrot M, Pierre AF, Waddell TK, Keshavjee S. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011 Apr 14;364(15):1431-40. doi: 10.1056/NEJMoa1014597."
            }, 
            {
                "PMID": "17184674", 
                "citation": "Oto T, Levvey BJ, Whitford H, Griffiths AP, Kotsimbos T, Williams TJ, Snell GI. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg. 2007 Jan;83(1):257-63."
            }, 
            {
                "PMID": "15848310", 
                "citation": "Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W. Extended donor criteria for lung transplantation--a clinical reality. Eur J Cardiothorac Surg. 2005 May;27(5):757-61."
            }, 
            {
                "PMID": "17532422", 
                "citation": "Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, Liao Q, Eyjolfsson A, Gustafsson R, Sj\u00f6berg T. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007 Jun;83(6):2191-4."
            }, 
            {
                "PMID": "22386450", 
                "citation": "Valenza F, Rosso L, Coppola S, Froio S, Colombo J, Dossi R, Fumagalli J, Salice V, Pizzocri M, Conte G, Gatti S, Santambrogio L, Gattinoni L. \u03b2-adrenergic agonist infusion during extracorporeal lung perfusion: effects on glucose concentration in the perfusion fluid and on lung function. J Heart Lung Transplant. 2012 May;31(5):524-30. doi: 10.1016/j.healun.2012.02.001. Epub 2012 Mar 3."
            }, 
            {
                "PMID": "16678604", 
                "citation": "Botha P, Trivedi D, Weir CJ, Searl CP, Corris PA, Dark JH, Schueler SV. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg. 2006 May;131(5):1154-60."
            }, 
            {
                "PMID": "21620034", 
                "citation": "Valenza F, Rosso L, Pizzocri M, Salice V, Umbrello M, Conte G, Stanzi A, Colombo J, Gatti S, Santambrogio L, Iapichino G, Gattinoni L. The consumption of glucose during ex vivo lung perfusion correlates with lung edema. Transplant Proc. 2011 May;43(4):993-6. doi: 10.1016/j.transproceed.2011.01.122."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01967953"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Policlinico Hospital", 
            "investigator_full_name": "Franco Valenza, MD", 
            "investigator_title": "Assistant Professor Anaesthesia and Intensive Care, Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Duration of mechanical ventilation after transplantation", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "ICU length of stay after transplantation", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Policlinico Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Policlinico Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}